中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
25期
131-133
,共3页
消化性溃疡%中西医结合%雷贝拉唑
消化性潰瘍%中西醫結閤%雷貝拉唑
소화성궤양%중서의결합%뢰패랍서
Peptic ulcer%Integrated traditional Chinese and western medicine%Rabeprazole
目的：探讨中西医结合治疗小儿消化性溃疡的临床效果。方法选取85例消化性溃疡患儿作为研究对象，分为对照组42例与研究组43例。对照组给予常规西药治疗，研究组在对照组的基础上给予中药汤剂治疗。结果研究组的总有效率为95.35%，明显高于对照组的76.19%(P<0.05)；研究组的愈合率、Hp根除率均明显高于对照组(P<0.05)；研究组的不良反应发生率为11.63%，对照组为11.90%，两组比较，差异无统计学意义(P>0.05)。结论中西医结合治疗小儿消化性溃疡能有效提高愈合率与Hp根除率，效果显著，值得推广。
目的：探討中西醫結閤治療小兒消化性潰瘍的臨床效果。方法選取85例消化性潰瘍患兒作為研究對象，分為對照組42例與研究組43例。對照組給予常規西藥治療，研究組在對照組的基礎上給予中藥湯劑治療。結果研究組的總有效率為95.35%，明顯高于對照組的76.19%(P<0.05)；研究組的愈閤率、Hp根除率均明顯高于對照組(P<0.05)；研究組的不良反應髮生率為11.63%，對照組為11.90%，兩組比較，差異無統計學意義(P>0.05)。結論中西醫結閤治療小兒消化性潰瘍能有效提高愈閤率與Hp根除率，效果顯著，值得推廣。
목적：탐토중서의결합치료소인소화성궤양적림상효과。방법선취85례소화성궤양환인작위연구대상，분위대조조42례여연구조43례。대조조급여상규서약치료，연구조재대조조적기출상급여중약탕제치료。결과연구조적총유효솔위95.35%，명현고우대조조적76.19%(P<0.05)；연구조적유합솔、Hp근제솔균명현고우대조조(P<0.05)；연구조적불량반응발생솔위11.63%，대조조위11.90%，량조비교，차이무통계학의의(P>0.05)。결론중서의결합치료소인소화성궤양능유효제고유합솔여Hp근제솔，효과현저，치득추엄。
Objective To explore the clinical effect of integrated traditional Chinese and western medicine treating pep-tic in children. Methods 85 children with peptic ulcer were selected as research subjects and they were divided into the control group (n=42) and the research group (n=43).The control group received the treatment of regular western medicine,and the research group received decoction of traditional Chinese medicine on the basis of the control group. Results The total effective rate in the research group (95.35%) was significantly higher than that of the control group (76.19%) (P<0.05);recovery rate and Hp eradication rate in the research group were significantly higher than those in the control group (P<0.05);incidence rate of adverse effect was 11.63%in the research group and 11.90%in the control group,and the difference was not statistically significant (P>0.05). Conclusion Integrated traditional Chinese and west-ern medicine in the treatment of peptic ulcer for children helps effectively improve recovery rate and Hp eradication rate,which has a significant curative effect and worthy of clinical promotion.
